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Change in the Executive Editorial Team at JCFAs heralded in late 2012, a change in the Executive Editorial
Team would occur and commence in early 2014, at the
completion of Gerd Döring's term as Editor-in-Chief. Gerd was
the Editor-in-Chief from 2006 until his recent and untimely
death. He continued to support and lead the Journal's activities
throughout his illness and in fact prepared the content for the
Issues for the rest of 2013!
By necessity, the Editors agreed for Dr Harry Heijerman to
become Acting Editor-in-Chief, allowing the Editor-in-Chief
Elect the opportunity to learn more about the current status of
the Journal and establish his team to allow continuation of the
growth and reputation of the world's only journal focused
directly on Cystic Fibrosis. The Board of the ECFS approved
the appointment of Dr Scott Bell as the new Editor-in-Chief and
he will be supported by Dr Dominik Hartl and until June 2014,
Harry Heijerman, as Deputy Editors for JCF. A replacement
Deputy Editor will be appointed and announced in Gothenburg
at the European CF Conference. The Executive Team will take
on their new roles from 1 December 2013.
Scott Bell is an adult pulmonologist based in Brisbane,
Australia and is Director of the Adult CF Centre at The Prince
Charles Hospital (TPCH), which provides care for 300 adults
with CF. After completing his pulmonology training in Sydney,
he undertook training in adult cystic fibrosis and a research
degree in Cardiff, UK (MD) and then a Lung Transplantation
Fellowship back in Sydney. He was appointed to TPCH in
1996 and moved with his family to Brisbane. In parallel, he
established a Lung Transplant Program and secured formal
funding for a state-wide adult CF centre, which he became
the inaugural Director. Since then he has led a large clinical
research programme and his current research interests include
CF microbiology, emerging complications of adults with
CF and the role of new therapies for CF. He is interested in
clinical guideline development and evaluation and is currently
co-leading the major review of the Australian Standards of CF
Care and Guidelines for Health Care Workers with CF, and a
member of the group reviewing the Australian Bronchiectasis
Guidelines. He has several roles supporting ECFS activities
and some of these include participation in the major review
of the European CF Standards of Care (Best Practice Group
Deputy Chair), current chair of the Pulmonology/Immunology
Assembly for the Organising Committee of the ECFC and was
a member of the Consensus Study Group for the Treatment of1569-1993/$ -see front matter © 2013 Published by Elsevier B.V. on behalf of Eur
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2012). He was appointed as an Associate Editor for JCF in
2005.
Dominik Hartl is a paediatric pulmonologist/ID physician
in Tübingen, Germany, and head of the Translational CF
Research Group at the University of Tübingen. After completing
his paediatric MD training in Munich, Germany, he has spent
post-doc research periods at the University of Amsterdam and
the Yale University, New Haven, USA. He is interested in
understanding the mechanisms leading to CF lung disease and
their diagnostic and therapeutic implications, ranging from
genetic/molecular to murine and patient studies. He chairs
the research community panel (FGM) of the German CF
Association. He was appointed as an Associate Editor for JCF
in 2012.
With the delivery of a contemporary communication modality
in the era of open access journals, social media and the ever
increasing depth of scientific information, maintaining relevance
and impact of a journal is challenging.We acknowledge the small
decline in JCF's impact factor for 2012 and our team will work
hard to examine ways to continue the Journals' growth including
adaptation of innovative methods to communicate the work you
publish in JCF to our readers.Retirement of Steven Conway from the Editorial Board
Steven qualified at St George's Hospital London in 1978
and worked in paediatric units in Leeds from 1982, under the
mentorship of Dr Jim Littlewood. He was appointed as a
consultant in 1988. He led the development of the regional CF
Unit for adult care (initially at Seacroft Hospital), a role to
which he gave a unique perspective as a paediatrician with
sub-specialty training in infectious diseases. He juggled this
role, in addition to a busy paediatric practice and a leadership
role at the regional paediatric CF unit at St James Hospital,
Leeds. Steven has published widely throughout his career and
always focused on asking clinically relevant questions that
would enhance the delivery of care in the clinic to his patients.
Steven joined the Editorial Board of JCF in January 2005 and
became a member of the Executive Editorial Team. We are
tremendously grateful for his time and expertise in this role
with JCF that he always embraced with energy and wisdom.opean Cystic Fibrosis Society.
546 EditorialWe wish him and his family well in his retirement from the
NHS.
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